Theo van Voorthuizen

Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trial

Vivianne C. G. Tjan‐Heijnen, Irene E.G. van Hellemond, Petronella G.M. Peer et al. · The Lancet Oncology · 2017 · 157 citations

Medicine, Clinical Trials, Gynecology +10

First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group

Marinde J. G. Bond, Karen Bolhuis, O. J. L. Loosveld et al. · The Lancet Oncology · 2023 · 153 citations · Full text

Surgical Oncology, Hepatology, Medicine +7

Practical diagnostic management of patients with clinically suspected deep vein thrombosis by clinical probability test, compression ultrasonography, and D-dimer test

Lidwine W. Tick, Evelien Ton, Theo van Voorthuizen et al. · The American Journal of Medicine · 2002 · 102 citations

Compression Ultrasonography, Pulmonary Embolism, Thrombosis +12

Randomized phase III trial of S-1 versus capecitabine in the first-line treatment of metastatic colorectal cancer: SALTO study by the Dutch Colorectal Cancer Group

Johannes J.M. Kwakman, Lieke H. J. Simkens, Johan M. van Rooijen et al. · Annals of Oncology · 2017 · 81 citations

Trajectories of health-related quality of life and psychological distress in patients with colorectal cancer: A population-based study

Seyed M. Qaderi, J. Van Der Heijden, Rob H.A. Verhoeven et al. · European Journal of Cancer · 2021 · 51 citations · Full text